Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial
Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added. The prior government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a site-wide government funding notice and updated the revision tag to v3.4.1, replacing the previous v3.4.0 revision.SummaryDifference0.2%

- Check28 days agoChange DetectedShow glossary added; metadata updates include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0, while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedLocations section updated to include a broader list of study sites across the United States and Canada, and a revision tag v3.3.3.SummaryDifference1%

- Check85 days agoChange DetectedRevision updated to v3.3.2. The previous revision v3.3.1 has been removed.SummaryDifference0.0%

- Check93 days agoChange DetectedPublications section updated: added that publications are automatically filled from PubMed. The revision label was updated to v3.3.1, replacing the previous text referring to PubMed publications and revision v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.